If you want to sue your health insurance company in federal court because they denied your claim or they’re not paying your medical bills in a timely fashion, chances are you can’t. But some Democrats want to change that.
The public option insurance plan has fallen off the national radar, despite being a major point of contention between moderates and progressives just a year ago during President Biden's campaign.
The seller of the brain-cancer drug Gleostine has pulled out of a federal discount program for Medicare patients, leaving some struggling to pay for a therapy that can cost as much as $1,000 per capsule. NextSource Biotechnology LLC’s decision to leave the program, rendering its drug ineligible for the Medicare Part D drug benefit, comes after the Miami company raised the drug’s price exponentially since acquiring rights in 2013. Gleostine, which treats a tumor known as glioblastoma and other brain cancers, is off-patent but has no generic alternative.
Colorado Gov. Jared Polis on Wednesday signed into law a public health care option, making it the third state in the US to approve the creation of a government-run health insurance plan to be sold alongside commercial coverage on the Affordable Care Act’s insurance marketplaces.
A special enrollment period for older Coloradans to sign up for certain Medicare supplement insurance ends June 30. The Colorado Division of Insurance opened up the six-month period after federal changes kept newly eligible people from purchasing some of the supplement policies, which are often sold by private companies to help with costs for copays, deductibles and other things that aren’t covered by original Medicare. People that buy supplemental policies, called Medigap, can do so without having their health or risk evaluated in order to get a plan, said Vincent Plymell, assistant commissioner for the agency.
Recent health insurance market consolidation linked to Obamacare regulations has raised premiums for employers and individuals. Consolidation happens when either producers in a market leave or two or more producers merge into one company. Either way, it means a larger market share for the companies that remain. In recent years, consolidation due to insurers exiting a market has become more common, especially in the Obamacare exchanges. According to data from the conservative think tank Heritage Foundation, 345 insurers offered coverage on the exchanges in 2013. By 2019, that had fallen to 202.